Where can I learn more about this study?
You can find more information about this study on the websites listed below. If more
information about the study results is available, it can also be found here.
> www.clinicaltrials.gov. Once you are on the website, type “NCT03968978”
into the search box and click “Search”.
> www.clinicaltrialsregister.eu. Once you are on the website, click
“Home and Search”, then type “2018-004588-30” in the search
box and click “Search”.
> www.AstraZenecaClinicalTrials.com. Once you are on the website, type
“D5180C00011” into the search box, and click “Find a Study”.
Full Study Title: A Multicentre, Randomised, Open-label, Parallel-group,
Functionality, and Performance Study of an Accessorised Pre-filled Syringe and
Autoinjector with Home-administered Subcutaneous Tezepelumab in Adolescent and
Adult Subjects with Severe Asthma (PATH-HOME)
AstraZeneca AB Protocol Number: D5180C00011
National Clinical Trials number: NCT03968978
EudraCT number: 2018-004588-30
AstraZeneca AB sponsored this study and has its headquarters in Södertälje, Sweden.
The phone number for the AstraZeneca Information Center is +1-877-240-9479.
Thank you!
Participants in clinical studies belong to a large community of people who
take part in clinical research around the world. They help researchers answer
important health questions and find medical treatments for patients.
The Center for Information & Study on Clinical Research Participation (CISCRP) is a non-profit organization focused
on educating and informing the public about clinical research participation. CISCRP is not involved in recruiting
participants for clinical studies, nor is it involved in conducting clinical studies.
CISCRP | One Liberty Square, Suite 1100 • Boston, MA 02109 | 1-877-MED-HERO | www.ciscrp.org
Version 1.1 2021_01_08
12 | Clinical Study Results